University of Pennsylvania 7th annual conference on statistical issues in clinical trials: Current issues regarding the use of biomarkers and surrogate endpoints in clinical trials (morning panel discussion)

被引：0
作者：
Daniels, Michael [1 ]
Frangakis, Constantine [2 ]
Charu, Vivek [2 ]
Ghosh, Debashis [3 ]
Mietlowski, William L.
Kumm, Elizabeth [4 ]
Joffe, Marshall [5 ]
Taylor, Jeremy [6 ]
Wang, Songbai [7 ]
Baker, Stuart [8 ]
Weisberg, Herb
Hu, Chen [9 ]
Ellenberg, Susan [5 ]
机构：
[1] Univ Texas Austin, Austin, TX 78712 USA
[2] Johns Hopkins Univ, Baltimore, MD 21218 USA
[3] Univ Colorado, Boulder, CO 80309 USA
[4] I3Statprobe, Aalborg, Denmark
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Janssen Diagnost, Raritan, NJ USA
[8] NCI, Bethesda, MD 20892 USA
[9] Amer Coll Radiol, Reston, VA USA
来源：
CLINICAL TRIALS | 2015年 / 12卷 / 04期
关键词：
MARKERS;
D O I：
10.1177/1740774515590090
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：323 / 332
页数：10
相关论文
共 20 条
  • [1] [Anonymous], P 25 AAAI C ART INT
  • [2] Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes
    Baker, Stuart G.
    Kramer, Barnett S.
    [J]. CLINICAL TRIALS, 2015, 12 (04) : 299 - 308
  • [3] Bareinboim E., 2013, P 27 NATL C ARTIFICI, P95, DOI DOI 10.1609/AAAI.V27I1.8692
  • [4] Bareinboim E., 2012, P AAAI C ARTIFICIAL, Vvol. 26, P698
  • [5] A General Algorithm for Deciding Transportability of Experimental Results
    Bareinboim, Elias
    Pearl, Judea
    [J]. JOURNAL OF CAUSAL INFERENCE, 2013, 1 (01) : 107 - 133
  • [6] SELECTING OPTIMAL TREATMENT IN CLINICAL-TRIALS USING COVARIATE INFORMATION
    BYAR, DP
    CORLE, DK
    [J]. JOURNAL OF CHRONIC DISEASES, 1977, 30 (07): : 445 - 459
  • [7] Analysis of randomized comparative clinical trial data for personalized treatment selections
    Cai, Tianxi
    Tian, Lu
    Wong, Peggy H.
    Wei, L. J.
    [J]. BIOSTATISTICS, 2011, 12 (02) : 270 - 282
  • [8] SURROGATE END-POINTS
    ELLENBERG, SS
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 457 - 459
  • [9] Consistent causal effect estimation under dual misspecification and implications for confounder selection procedures
    Gruber, Susan
    van der Laan, Mark J.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2015, 24 (06) : 1003 - 1008
  • [10] Surrogate markers for time-varying treatments and outcomes
    Hsu, Jesse Y.
    Kennedy, Edward H.
    Roy, Jason A.
    Stephens-Shields, Alisa J.
    Small, Dylan S.
    Joffe, Marshall M.
    [J]. CLINICAL TRIALS, 2015, 12 (04) : 309 - 316
12